Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

04. März 2025 02:30 ET | Quelle: Allegro NV

Allegro reports positive safety data for its injectable osteoarthritis treatment in three preclinical studies

Hydrocelin is potentially a first-in-class disease-modifying injectable treatment for osteoarthritisPivotal clinical trial in osteoarthritis patients on track to start in 2025 Liege, Belgium – 4...
31. März 2022 10:15 ET | Quelle: BusPatrol

Red Means Go? Thousands of Cars Illegally Pass Stopped School Buses in Tulare County Stop-Arm Study

Tulare County, CA, March 31, 2022 (GLOBE NEWSWIRE) -- Visalia Unified School District partnered with BusPatrol to trial stop-arm safety technology and see how often cars illegally pass stopped...
06. Dezember 2021 09:00 ET | Quelle: Biofrontera Inc.

Biofrontera Inc. Enrolls First Subject in Phase 1 Safety Study Evaluating Photodynamic Therapy with Three Tubes of Ameluz®

WOBURN, Mass., Dec. 06, 2021 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today that...
14. August 2017 08:30 ET | Quelle: LinkedIn

Hemispherx Human Safety Study of Intranasal Ampligen® with Influenza Vaccine Shows Ampligen was Generally Well-Tolerated

PHILADELPHIA, Aug. 14, 2017 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE MKT:HEB) announced that it has commenced full data analysis of an intranasal human safety study of Ampligen® plus FluMist®...